EX-23.1 8 nvus-ex231_110.htm EX-23.1 nvus-ex231_110.htm

 

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in Registration Statement Nos. 333-200413, 333-203032, 333-210058, 333-216432, 333-232428 and 333-237380 on Form S-8 and Registration Statement Nos. 333-226286 and 333-251305 on Form S-3 of our report dated March 30, 2021, relating to the consolidated financial statements of Eledon Pharmaceuticals, Inc., appearing in this Annual Report on Form 10-K of Eledon Pharmaceuticals, Inc. for the year ended December 31, 2020.

 

 

 

/s/ KMJ Corbin & Company LLP

 

Irvine, California

March 30, 2021